A suite of policy tools
Cullman acknowledged there is no single fix, describing the approach as "a suite of different policies working together, sequenced in the right order."
For vitamins, where domestic production has largely disappeared, the strategy is to "build and protect," she said. For amino acids, where some U.S. capacity remains, it is to "protect and build."
Policy tools under consideration include domestic support programs modeled on semiconductor industry incentives, research funding for biofermentation-based domestic vitamin production, regulatory streamlining through frameworks like the FAST-41 initiative (or Title 41 of the Fixing America’s Surface Transportation Act), and investment vehicles such as USDA Rural Development grants and Export-Import Bank loans.
On trade, AFIA is exploring preferential agreements with suppliers in Europe, Thailand, Indonesia and India to diversify sourcing. Cullman was careful to frame the issue as one of supply diversity, not anti-China sentiment.
"This isn’t anything that’s negative about China or China suppliers, but it is negative about a lack of diversity in the supply chain," she said.